| SpectraBase Spectrum ID |
2mAiJkxQFBw |
| Name |
N-(1-[2,5-Dimethoxy-4-(propan-2-yl)phenyl]propan-2-yl)-2-methoxybenzamide |
| Classification |
Amphetamine analog designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
371.209658414 u |
| Formula |
C22H29NO4 |
| InChI |
InChI=1S/C22H29NO4/c1-14(2)18-13-20(26-5)16(12-21(18)27-6)11-15(3)23-22(24)17-9-7-8-10-19(17)25-4/h7-10,12-15H,11H2,1-6H3,(H,23,24) |
| InChIKey |
OOZCFUAYCUKTOO-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
371.477 g/mol |
| Nominal Mass |
371 u |
| Quality |
853 |
| Retention Index |
2659 |
| SMILES |
C=1(C(NC(CC=2C(=CC(=C(C2)OC)C(C)C)OC)C)=O)C(=CC=CC1)OC |
| SPLASH |
splash10-0079-2960000000-890ea176a5782886cbdb |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-(1-(2,5-dimethoxy-4-(propan-2-yl)phenyl)propan-2-yl)-2-methoxybenzamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_022766 |
![N-(1-[2,5-Dimethoxy-4-(propan-2-yl)phenyl]propan-2-yl)-2-methoxybenzamide](/api/spectrum/2mAiJkxQFBw/structure.png?h=300&w=458 "N-(1-[2,5-Dimethoxy-4-(propan-2-yl)phenyl]propan-2-yl)-2-methoxybenzamide")
